Literature DB >> 31182619

Persistent Toxoplasma Infection of the Brain Induced Neurodegeneration Associated with Activation of Complement and Microglia.

Ye Li1, Emily G Severance1, Raphael P Viscidi2, Robert H Yolken1, Jianchun Xiao3.   

Abstract

Toxoplasma gondii, a common neurotropic parasite, is increasingly being linked to neuropsychiatric disorders, including schizophrenia, Alzheimer's disease, and Parkinson's disease. However, the pathogenic mechanisms underlying these associations are not clear. Toxoplasma can reside in the brain for extensive periods in the form of tissue cysts, and this process requires a continuous immune response to prevent the parasite's reactivation. Because neuroinflammation may promote the onset and progression of neurodegenerative diseases, we investigated neurodegeneration-associated pathological changes in a mouse model of chronic Toxoplasma infection. Under conditions of high-grade chronic infection, we documented the presence of neurodegeneration in specific regions of the prefrontal cortex, namely, the anterior cingulate cortex (ACC) and somatomotor cortex (SC). Neurodegeneration occurred in both glutamatergic and GABAergic neurons. Neurons that showed signs of degeneration expressed high levels of CX3CL1, were marked by profoundly upregulated complement proteins (e.g., C1q and C3), and were surrounded by activated microglia. Our findings suggest that chronic Toxoplasma infection leads to cortical neurodegeneration and results in CX3CL1, complement, and microglial interactions, which are known to mediate the phagocytic clearance of degenerating neurons. Our study provides a mechanistic explanation for the link between Toxoplasma infection and psychiatric disorders.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  CX3CL1; Toxoplasma gondiizzm321990; complement; microglia; neurodegeneration; neuroinflammation

Mesh:

Substances:

Year:  2019        PMID: 31182619      PMCID: PMC6652752          DOI: 10.1128/IAI.00139-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging Cohort.

Authors:  Vishwajit L Nimgaonkar; Robert H Yolken; Tianxiu Wang; Chung-Chou H Chang; Lora McClain; Eric McDade; Beth E Snitz; Mary Ganguli
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

2.  Predominant interferon-γ-mediated expression of CXCL9, CXCL10, and CCL5 proteins in the brain during chronic infection with Toxoplasma gondii in BALB/c mice resistant to development of toxoplasmic encephalitis.

Authors:  Xiangshu Wen; Tomoya Kudo; Laura Payne; Xisheng Wang; Laurel Rodgers; Yasuhiro Suzuki
Journal:  J Interferon Cytokine Res       Date:  2010-09       Impact factor: 2.607

3.  Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer?

Authors:  Mahmoud Mahami-Oskouei; Faezeh Hamidi; Mahnaz Talebi; Mehdi Farhoudi; Ali Akbar Taheraghdam; Tohid Kazemi; Homayoun Sadeghi-Bazargani; Esmaeil Fallah
Journal:  Parasitol Res       Date:  2016-04-23       Impact factor: 2.289

4.  Prenatal depression and anxiety in Toxoplasma gondii-positive women.

Authors:  Maureen W Groër; Robert H Yolken; J-C Xiao; Jason W Beckstead; Dietmar Fuchs; Shyam S Mohapatra; Andreas Seyfang; Teodor T Postolache
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

Review 5.  Inflammation in neurodegenerative diseases.

Authors:  Sandra Amor; Fabiola Puentes; David Baker; Paul van der Valk
Journal:  Immunology       Date:  2010-02       Impact factor: 7.397

Review 6.  Microglia and neurodegeneration: the role of systemic inflammation.

Authors:  Colm Cunningham
Journal:  Glia       Date:  2012-06-06       Impact factor: 7.452

Review 7.  Emotional and behavioral symptoms in neurodegenerative disease: a model for studying the neural bases of psychopathology.

Authors:  Robert W Levenson; Virginia E Sturm; Claudia M Haase
Journal:  Annu Rev Clin Psychol       Date:  2014-01-15       Impact factor: 18.561

Review 8.  The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.

Authors:  Jessy John Alexander; Aileen Judith Anderson; Scott Robert Barnum; Beth Stevens; Andrea Joan Tenner
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

Review 9.  Protein aggregation and neurodegenerative disease.

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

10.  Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African trypanosomiasis.

Authors:  Jean Rodgers; Barbara Bradley; Peter G E Kennedy
Journal:  Methods       Date:  2017-06-19       Impact factor: 3.608

View more
  11 in total

Review 1.  Microglia in CNS infections: insights from Toxoplasma gondii and other pathogens.

Authors:  Maureen N Cowan; Ish Sethi; Tajie H Harris
Journal:  Trends Parasitol       Date:  2022-01-14

2.  Helminthic dehydrogenase drives PGE2 and IL-10 production in monocytes to potentiate Treg induction.

Authors:  Vitka Gres; Fiona Henkel; Ulrich Fabien Prodjinotho; Matthew Lacorcia; Ramona Dandl; Martin Haslbeck; Veronika Schmidt; Andrea Sylvia Winkler; Chummy Sikasunge; Per-Johan Jakobsson; Philipp Henneke; Julia Esser-von Bieren; Clarissa Prazeres da Costa
Journal:  EMBO Rep       Date:  2022-03-31       Impact factor: 9.071

3.  Toxoplasma infection induces microglia-neuron contact and the loss of perisomatic inhibitory synapses.

Authors:  Gabriela L Carrillo; Valerie A Ballard; Taylor Glausen; Zack Boone; Joseph Teamer; Cyrus L Hinkson; Elizabeth A Wohlfert; Ira J Blader; Michael A Fox
Journal:  Glia       Date:  2020-03-11       Impact factor: 7.452

4.  Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells.

Authors:  Makoto Kubo; Ryuichi Nagashima; Mitsue Kurihara; Fumitaka Kawakami; Tatsunori Maekawa; Koji Eshima; Etsuro Ohta; Hirotomo Kato; Fumiya Obata
Journal:  Int J Mol Sci       Date:  2020-03-10       Impact factor: 5.923

5.  Depletion of Intracellular Glutamine Pools Triggers Toxoplasma gondii Stage Conversion in Human Glutamatergic Neurons.

Authors:  Hironori Bando; Yasuhiro Fukuda; Nina Watanabe; Jeje Temitope Olawale; Kentaro Kato
Journal:  Front Cell Infect Microbiol       Date:  2022-01-13       Impact factor: 5.293

Review 6.  Comparative Review of Microglia and Monocytes in CNS Phagocytosis.

Authors:  Megumi Andoh; Ryuta Koyama
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

7.  Persisting Microbiota and Neuronal Imbalance Following T. gondii Infection Reliant on the Infection Route.

Authors:  Timothy French; Johannes Steffen; Albert Glas; Lisa Osbelt; Till Strowig; Björn H Schott; Thomas Schüler; Ildiko Rita Dunay
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

Review 8.  New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction.

Authors:  Naotaka Izuo; Atsumi Nitta
Journal:  J Pers Med       Date:  2021-05-03

9.  Toxoplasma gondii infection damages the perineuronal nets in a murine model.

Authors:  Ywlliane da Silva Rodrigues Meurer; Ramayana Morais de Medeiros Brito; Valeria Palheta da Silva; Joelma Maria de Araujo Andade; Sarah Sophia Guedes Linhares; Antonio Pereira Junior; Valter Ferreira de Andrade-Neto; Andrea Lima de Sá; Claudio Bruno Silva de Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2020-09-11       Impact factor: 2.743

10.  Toxoplasma Infection Induces Sustained Up-Regulation of Complement Factor B and C5a Receptor in the Mouse Brain via Microglial Activation: Implication for the Alternative Complement Pathway Activation and Anaphylatoxin Signaling in Cerebral Toxoplasmosis.

Authors:  Noriko Shinjyo; Kenji Hikosaka; Yasutoshi Kido; Hiroki Yoshida; Kazumi Norose
Journal:  Front Immunol       Date:  2021-02-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.